CXCL13 Is an Indicator of Germinal Center Activity and Alloantibody Formation Following Transplantation
Background. Donor-specific antibodies (DSA) are a recognized cause of allograft injury, yet biomarkers that indicate their development posttransplant or guide management are not available. CXCL13 (chemokine [C-X-C motif] ligand 1) is a chemoattractant produced within secondary lymphoid organs necess...
Guardado en:
Autores principales: | Emma S. Crichton, MD, MPH, Shan Zeng, MD, PhD, G. Michael La Muraglia, II, PhD, I. Raul Badell, MD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/944df3f4cb9c4559bf0b7959bcd41b16 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
por: Christopher J. Mowry, MD, et al.
Publicado: (2021) -
Lateral Thoracic Artery Can Stabilize Circulation in the Pectoralis Major Myocutaneous Pedicle Flap: Single-center, Prospective, Uncontrolled Case Series
por: Shinji Kumegawa, MD, et al.
Publicado: (2021) -
Discordance Between SARS-CoV-2–specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients
por: Mario Fernández-Ruiz, MD, PhD, et al.
Publicado: (2021) -
Neurogenic Orthostatic Hypotension: a Common Complication of Successful Pancreas Transplantation
por: Samantha A. Kuten, PharmD, et al.
Publicado: (2021) -
SARS-CoV-2–specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19
por: Dominique Bertrand, MD, et al.
Publicado: (2021)